Propafenone
Product Images NDC 21695-814

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propafenone (NDC 21695-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 01)

FDA Label Image

Figure1 (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 02)

FDA Label Image

Propafenone HCl 325mg (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 03)

Propafenone HCl 325mg (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 03)
This is a description of a medicine called Propafenone HCI 326mg, which comes in a bottle containing 60 capsules. Each capsule includes Propafenone and Hcl325mg, and they are orange opaque with "par/ 210" printed in black ink on the cap and "par/ 210" printed in black ink on the white opaque body. The medicine is manufactured by Par Pharmaceutical Companies Inc. and distributed by Physician Partner. It should be stored at a controlled room temperature between 15°-30°C (59°-86°F) and kept out of the reach of children. The rest of the text appears to be irrelevant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.